Baroda BNP Paribas Health And Wellness Fund · Direct · Growth
NAV
₹10.1193
as of 16 Jun 2026
Expense Ratio
—
see scheme documents
Lumpsum returns (CAGR)
- 1Y
- —
- 3Y
- —
- 5Y
- —
- Since Inception
- +1.19%
SIP returns (XIRR)
- 1Y
- —
- 3Y
- —
- 5Y
- —
- Since Inception
- +8.42%
Performance Comparison
Sectoral allocation
as of 30 Apr 2026- Pharmaceuticals & Biotechnology68.00%
- Healthcare Services18.00%
- Insurance7.00%
- Retailing2.00%
- IT - Services2.00%
- Healthcare Equipment & Supplies1.00%
Each sector links to the mutual funds most exposed to it.
Thinking about Baroda BNP Paribas Health And Wellness Fund · Direct · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Fund Details
Available transactions
Portfolio holdings
portfolio shared with Baroda BNP Paribas Health and Wellness Fund Regular Growth
- 1Sun Pharmaceutical Industries Limited9.38%
- 2Lupin Limited6.09%
- 3Ipca Laboratories Limited5.34%
- 4Abbott India Limited5.28%
- 5Torrent Pharmaceuticals Limited5.13%
- 6Laurus Labs Limited4.78%
- 7Fortis Healthcare Limited4.35%
- 8Apollo Hospitals Enterprise Limited4.32%
- 9Jb Chemicals & Pharmaceuticals Limited4.24%
- 10Astrazeneca Pharma India Limited4.03%
Investment Objective
Baroda BNP Paribas Health And Wellness Fund · Direct · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
Baroda BNP Paribas Health And Wellness Fund · Direct · Growth is a Sectoral / Thematic mutual fund offered by Baroda BNP Paribas Mutual Fund. The fund has been operational for over 0 years.
Who Should Invest?
- •Investors with a high risk appetite seeking long-term wealth creation
- •Investors with an investment horizon of 5 years or more
- •SIP investors who can benefit from rupee cost averaging during market fluctuations